News

Medigene presents data on the successful production of AML DC vaccines at AACR conference

SHOW RELEASE

Medigene participates at five upcoming conferences

SHOW RELEASE

Clinical data for DC vaccine in prostate cancer IIT study presented by Oslo University

SHOW RELEASE

Medigene appoints Dr. Kai Pinkernell to the Executive Management Board as CMO/CDO

SHOW RELEASE

Medigene publishes 2017 annual report and announces start of clinical trial with TCR immunotherapy MDG1011

SHOW RELEASE

Medigene presents at upcoming conferences

SHOW RELEASE

Medigene strengthens its patent portfolio with a European patent covering T cell identification method

SHOW RELEASE

Medigene announces participation at four upcoming conferences

SHOW RELEASE

Medigene receives approvals for its first clinical trial with TCR therapy MDG1011

SHOW RELEASE

'Deutsche Krebshilfe Preis' awarded to Professor Dolores Schendel

SHOW RELEASE

Medigene strengthens its patent portfolio with a US patent on a tagged TCR

SHOW RELEASE

Medigene announces participation at six upcoming investor and scientific conferences

SHOW RELEASE

Expitope 2.0 helps to identify safer antigens for immunotherapy of cancer

SHOW RELEASE

Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells

SHOW RELEASE

Medigene sells US-rights for VeregenĀ® and raises financial guidance 2017

SHOW RELEASE